From c0ea464476c6da1e83d46ce14a2c23f54ab27a64 Mon Sep 17 00:00:00 2001 From: Kisa Date: Sat, 11 Apr 2026 19:52:28 -0400 Subject: [PATCH] feat: Signal CGM asset package v1 + sales agent agreement Co-Authored-By: Claude Sonnet 4.6 --- .../DMEPOS/sales-agent-agreement-template.md | 114 +++++++++++++++++ .../DMEPOS/signal-cgm-asset-package-v1.md | 121 ++++++++++++++++++ 2 files changed, 235 insertions(+) create mode 100644 Projects/DMEPOS/sales-agent-agreement-template.md create mode 100644 Projects/DMEPOS/signal-cgm-asset-package-v1.md diff --git a/Projects/DMEPOS/sales-agent-agreement-template.md b/Projects/DMEPOS/sales-agent-agreement-template.md new file mode 100644 index 0000000..d8fe4cf --- /dev/null +++ b/Projects/DMEPOS/sales-agent-agreement-template.md @@ -0,0 +1,114 @@ +# Independent Sales Representative Agreement + +**STTIL Solutions LLC** +**Signal CGM Asset — Sales Agent Agreement** + +--- + +This Independent Sales Representative Agreement ("Agreement") is entered into +as of __________________, 2026 ("Effective Date") by and between: + +**Company:** STTIL Solutions LLC, a Florida limited liability company +("Company"), and + +**Agent:** ________________________________________________ ("Agent"). + +--- + +## 1. Appointment and Scope + +Company appoints Agent as a non-exclusive independent sales representative +authorized to identify and introduce prospective buyers ("Prospects") for the +Signal CGM software asset package ("Asset"). Agent's role is limited to +identification and introduction of Prospects. Agent has no authority to +negotiate, modify, or execute any agreement on behalf of Company. + +## 2. Commission + +Agent shall earn a commission of **fifteen percent (15%)** of the gross sale +price received by Company upon the close of a qualifying transaction with a +Prospect introduced by Agent. A transaction qualifies if: (a) Agent provided +the initial written introduction of the Prospect to Company, (b) the transaction +closes within the Term or within ninety (90) days after expiration of the Term, +and (c) Company receives full or initial payment from the Prospect. + +Commission is due and payable within fifteen (15) business days of Company's +receipt of the sale proceeds. No commission is earned until funds are received +by Company. + +## 3. Term + +This Agreement commences on the Effective Date and continues for **ninety (90) +days** unless earlier terminated by either party upon ten (10) days' written +notice. The Agreement may be renewed by mutual written consent of both parties. + +## 4. Agent Representations and Warranties + +Agent shall not make any representations, warranties, or guarantees to +Prospects regarding the Asset, its fitness for any particular purpose, +regulatory compliance, or future development roadmap beyond what is expressly +contained in the written asset package materials provided by Company. All +Prospect questions regarding technical specifications, compliance, or pricing +shall be referred to Company. + +## 5. Final Negotiation Authority + +All final terms of sale, including price, payment structure, transfer scope, +and representations, are negotiated and executed exclusively by Company. +Agent has no authority to bind Company to any term, discount, or commitment. + +## 6. Independent Contractor + +Agent is an independent contractor and not an employee, partner, or agent of +Company for any purpose other than as expressly set forth herein. Agent is +solely responsible for all taxes, insurance, and expenses incurred in +performing under this Agreement. Company shall issue a Form 1099 to Agent +for commissions paid, as required by applicable law. + +## 7. Confidentiality + +Agent shall keep confidential all non-public information regarding the Asset, +pricing, Prospects, and Company business provided under this Agreement. Agent +shall not disclose such information to any third party without Company's prior +written consent. + +## 8. Governing Law + +This Agreement shall be governed by and construed in accordance with the laws +of the State of **Florida**, without regard to its conflict of law provisions. +Any dispute arising under this Agreement shall be resolved in the courts of +Florida, and both parties consent to jurisdiction therein. + +## 9. Entire Agreement + +This Agreement constitutes the entire agreement between the parties regarding +its subject matter and supersedes all prior representations, negotiations, and +understandings. Amendments must be in writing and signed by both parties. + +--- + +## Signatures + +**STTIL Solutions LLC** + +Signature: _________________________________ + +Name: _____________________________________ + +Title: ____________________________________ + +Date: _____________________________________ + +--- + +**Agent** + +Signature: _________________________________ + +Name: _____________________________________ + +Address: ___________________________________ + +___________________________________________ + +Date: _____________________________________ diff --git a/Projects/DMEPOS/signal-cgm-asset-package-v1.md b/Projects/DMEPOS/signal-cgm-asset-package-v1.md new file mode 100644 index 0000000..cd7acea --- /dev/null +++ b/Projects/DMEPOS/signal-cgm-asset-package-v1.md @@ -0,0 +1,121 @@ +# Signal CGM — Asset Package | Executive Summary + +**STTIL Solutions LLC | Confidential | April 2026** + +--- + +## Market Opportunity + +The CGM DMEPOS market is entering a window of structural stress that rewards +suppliers with proactive coverage management tooling. + +- **2028 Competitive Bidding (CB):** CMS is expanding CB to CGM categories. + Margin compression will accelerate. Suppliers that reduce denials and appeals + overhead gain a direct cost advantage over competitors still running manual, + reactive workflows. +- **Prior Authorization Expansion (April 13, 2026):** CMS implemented expanded + PA requirements for CGM and related DMEPOS categories. Every prior auth cycle + introduces a coverage gap risk. Suppliers need automated visibility into + those gaps to act before a claim touches a PA trigger. +- **Enrollment Moratorium:** CMS supplier enrollment moratoria in high-risk + areas are tightening the supply pool. Existing enrolled suppliers face + consolidation pressure and rising per-patient management burden — exactly + the problem Signal CGM is designed to reduce. +- **Denial Patterns:** CGM claims deny on predictable, preventable conditions: + coverage lapsed before refill, physician visit not renewed on the Medicare + 180-day cycle, quantity exceeds allowable without documentation. Signal CGM + flags all three before shipment, not after. + +The total addressable market is approximately 7,500 Medicare-enrolled DMEPOS +suppliers billing CGM. A conservative 1% penetration at $3,600 ARR = $2.7M ARR. +CMS projects CGM beneficiaries to exceed 3.2 million by 2028. + +--- + +## What Signal CGM Does + +Signal CGM is a B2B coverage worklist tool built for DMEPOS supplier back-office +teams. It replaces manual spreadsheet tracking with an automated, rule-driven +coverage clock. + +- **Coverage Clock:** Calculates coverage expiration per patient per device + using payer-specific wear-day rules (Dexcom G6/G7, Libre 2/3, Omnipod 5). + Medicare visit renewal (180 days) is tracked as a separate flag. +- **24-Hour Batch Worklist:** n8n orchestration runs nightly. Staff arrive to a + sorted worklist — `OUT_OF_COVERAGE`, `VISIT_DUE`, `REFILL_WINDOW`, `OK` — + with highest-urgency patients at the top. +- **Minimal PHI Surface:** The system ingests `patient_id`, `device_type`, + `shipment_date`, `quantity`, `payer` only. No names, SSNs, DOBs, or contact + information enter the system. The supplier's own staff map `patient_id` back + to identity in their existing systems (Brightree, EHR). All audit logs hash + identifiers before storage. +- **Self-Hosted:** Runs on supplier's own VPS or STTIL-managed Hostinger VPS. + Data never leaves the supplier's network. No third-party SaaS dependency + on the data path. + +--- + +## What's Included in the Sale + +| Asset | Description | +|-------|-------------| +| Full source code | Python/FastAPI backend, coverage calculator, audit logger, PostgreSQL models, payer rules config | +| Research library | DMEPOS market research v3, compliance roadmap v1, CB/PA regulatory analysis | +| BAA templates | Hostinger VPS BAA request template; operator BAA framework for customer agreements | +| Newsletter strategy | Subscriber acquisition strategy for DMEPOS supplier outreach (v1) | +| n8n workflows | Self-hosted batch trigger workflow exports | +| `CLAUDE.md` handoff | Full AI-assisted development context file — new owner can continue building with Claude Code with zero ramp-up loss | +| 30-day knowledge transfer | Live sessions with STTIL Solutions founder covering architecture, payer rule updates, compliance posture, and go-to-market | + +Buyer receives all intellectual property, documentation, and development context +as a clean, working asset. No vendor lock-in. No ongoing royalty. + +--- + +## Ideal Buyer Profile + +**Option A — DMEPOS Supplier (Direct User)** +A mid-size supplier billing 200–2,000 CGM patients/month who currently manages +coverage tracking in spreadsheets or Brightree custom fields. Immediate ROI +through denial reduction. Can deploy internally or white-label for peer suppliers. + +**Option B — Healthcare Operator / DME Platform** +A DMEPOS software vendor, billing company, or managed services operator looking +to add a differentiated coverage intelligence module to their existing platform. +Signal CGM integrates cleanly into existing FastAPI or Django stacks. + +**Option C — Consortium or Buying Group** +A DMEPOS buying group or GPO representing multiple suppliers. Acquire once, +deploy across member base. License to members as a value-add service. Buying +groups operating in markets with active CB expansion have the strongest urgency +case. + +--- + +## Investment Range + +**$25,000 — $60,000** (one-time asset acquisition) + +Range reflects buyer type and included transfer scope. Direct supplier buyers +at the lower end. Platform/operator buyers and consortium structures at the +higher end. All terms negotiated directly with STTIL Solutions LLC. + +No SaaS subscription required. No ongoing royalty. Buyer owns the asset outright. + +--- + +## Why Now + +- PA expansion is live as of April 13, 2026 — suppliers are feeling it now +- CB 2028 planning cycles begin at the supplier level 18–24 months out +- The enrollment moratorium is reducing the number of new entrants who can + absorb this problem with headcount — existing suppliers must solve it with tools +- Early buyer gets the asset before it is offered to competitors in their market +- 30-day knowledge transfer window is time-limited and not guaranteed after + initial close + +--- + +## Contact + +[CONTACT PLACEHOLDER]